Simultaneous measurements of nitric oxide (NO) (0-80 ppm) using a chemiluminescence monitor and two electrochemical monitors were performed during simulated paediatric mechanical ventilation. The mean difference (bias) between the chemiluminescence (Model 42H Thermo Environmental Instruments Inc) and an electrochemical monitor (Pulmonox Research and Development Corp) was 0.52±6.52 ppm (SD). The 95% confidence limits of the mean difference were 3.00 to -1.96 ppm and the limits of agreement between the two techniques were 13.56 to -12.52 ppm. The mean difference between the chemiluminescence monitor and another electrochemical monitor (NOxBox, Bedfont Scientific Inc) was -7.27±4.29 ppm. The 95% confidence limits of the mean difference were -9.02 to -5.56 ppm and limits of agreement of the two techniques were -16.13 to 1.55 ppm. These results suggest that electrochemical monitors may be used to guard against potentially toxic concentrations of NO (greater than 20 ppm). However they do not suggest that either of the electrochemical monitors may be used with confidence in lieu of the chemiluminescence monitor to regulate NO at low clinical NO levels (1-5 ppm).
Nitric oxide (NO) is an important molecule which has been implicated in an ever-increasing number of physiological, pharmacological and pathological processes. The introduction of gaseous NO into ventilator circuits has been recommended for management of pulmonary hypertension in newborns and paediatric cardiac patients as well as pulmonary hypertension and hypoxaemia in the adult respiratory distress syndrome (ARDS) [1] [2] [3] [4] [5] [6] .
Chemiluminescence detection is considered the gold standard for NO analysis although these monitors are cumbersome, noisy and expensive. Electrochemical monitors are now being used for routine detection of nitric oxide and nitrogen dioxide, but without adequate investigation of their accuracy. This study investigated the feasibility of substituting either of two smaller, silent and less expensive electrochemical monitors for a chemiluminescence monitor.
METHOD
Studies were performed with a chemiluminescence monitor (Model 42H, Thermo Environmental Instruments Inc) which measures NO in the range 0-5000 parts per million (ppm) with a detection limit of 0.05 ppm (50 parts per billion, ppb) and two electrochemical monitors (Pulmonox II electrochemical analyzer, Pulmonox Research & Development Corp: NOxBox electrochemical analyzer, Bedfont Scientific Inc) which measure NO in the ranges of 0-100 ppm (resolution 1 ppm) and 0-200 ppm respectively.
A continuous flow, pressure-limited paediatric ventilator (Bear Cub Infant Ventilator, Bear Medical Systems Inc) was set to simulate typical paediatric ventilation. At all flows, the circuit pressures were held constant at a peak inspiratory pressure of 20 cm H 2 O and a peak end-expiratory pressure of 5 cm H 2 O with an inspiratory time of 1.0 second. A disposable ventilator circuit, with a compressible volume of 150 ml, was used in conjunction with a servo-controlled humidifier (MR 700, Fisher and Paykel Healthcare Pty Ltd) with a reservoir volume of 120 ml and a 250 ml test lung. NO gas was introduced into the inspiratory limb of the circuit proximal to the humidifier via a low flow (0.0-1.0 l/min) air flow meter (Precision Medical Inc, Northampton, Pennsylvania, U.S.A.). The extraction port of the chemiluminescence monitor was sited in the expiratory limb of the circuit.
Gas was continuously sampled at a rate of 100 ml/min. The sampling site for the electrochemical monitors was sited 60 cm downstream from the chemiluminescence monitor to avoid interference ( Figure 1 ). Exhaled gases were scavenged to external atmosphere using hospital wall suction set at 20 cm H 2 O and a custom-made manifold for the ventilator expiratory valve. A T-piece was inserted into the scavenging circuit to enable entrainment of air and avoidance of interference to the expiratory valve. Zero calibration was performed on all monitors with high purity nitrogen (BOC Special Gases). NO calibration was performed with 80±1.8 ppm (BOC Special gases). Although the chemiluminescence and electrochemical monitors measure both NO and NO 2 , measurements of the latter were not recorded because a calibration gas for NO 2 measurement of suitable accuracy was not available.
NO (882±1.8 ppm) in nitrogen was introduced into the circuit at flows from 0.051/min to 0.45 or 0.51/min in gradations of 0.051/min. Ventilator gas flows were set at 5, 10 or 15 litres per minute to yield various concentrations of NO from approximately 4 to 90 ppm. The inspired oxygen concentration was kept constant at an FiO 2 of 0.3. Simultaneous measurements were recorded from the electrochemical monitors. Between each ventilator flow setting, the monitors were recalibrated and between each NO flow adjustment, a period of 120 seconds was allowed for equilibration. Readings were then recorded every 10 seconds for 120 seconds at each adjustment of NO flow. The mean values for simultaneous chemiluminescence and electrochemical NO recordings at each NO flow setting were calculated and their differences obtained (chemiluminescence minus electrochemical).
The differences between the means of simultaneous chemiluminescence and electrochemical NO measurements at each NO flow were plotted against the mean of their measurements (Figures 2 and 3 ). The 95% confidence limits of the mean differences were calculated using Student's t-distribution. The limits of agreement between the techniques were calculated according to Bland & Altman 7 . These statistics indicate the strength of agreement between two techniques which measure the same variable but do not permit a conclusion concerning the validity of either technique.
RESULTS
The mean difference between simultaneous measurements (n=29) from the Thermo Environmental chemiluminescence monitor and the Pulmonox electrochemical monitor was 0.52±-6.52 (standard deviation) ppm. The standard error of the differences was 1.21 ppm. The 95% confidence limits of the mean difference were 0.52±-2.048 (1.21), i.e. +3.00 to -1.96 ppm. The limits of agreement between the two techniques were 0.52±-2.048 (6.52) or 13.56 to -12.52 ppm. The mean difference between simultaneous measurements (n=26) from the Thermo Environmental chemiluminescence monitor and the Bedfont electrochemical monitor was -7.27±-4.29 (standard deviation) ppm. The standard error of the differences was 0.84 ppm. The 95% confidence limits of the mean difference were -7.29±-2.06 (0.84), i.e. -9.02 to -5.56 ppm. The limits of agreement between the two techniques were -7.29±-2.06 (4.29), i.e. 16.13 to +1.55 ppm.
DISCUSSION
Measurement of gaseous NO concentration is important to optimize therapy and to avoid toxic effects. In high concentration or prolonged use, NO may combine with haemoglobin to form methaemoglobin and interfere with oxygen transport. However, therapy with gaseous NO 20 ppm or less does not cause significant methaemoglobinaemia 8 . Nitrogen dioxide (NO 2 ) is formed when NO mixes with oxygen. The amount of NO 2 formed in a continuous flow pressure-limited paediatric ventilator circuit is dependent on the concentrations of NO and O 2 . Toxic concentrations of NO 2 were formed in a study when 50 ppm or more of NO was mixed with 90% oxygen 9 . Our commercially available NO/N 2 mixture lists the content of higher oxides of nitrogen, including NO 2 , as 1 to 2%.
Inhaled NO 2 oxidizes phospholipids and causes pulmonary toxicity 10, 11 . Health and occupational safety standards restrict continuous exposure to NO on a daily basis to 25 ppm NO and to NO 2 to 3 ppm. A short-term exposure limit of less than 5 ppm NO 2 is recommended but no value is given for NO 12, 13 .
The choice of instrumental methods currently available for determination of nitric oxide concentrations depends on several factors including the cost and accuracy of the monitors and the concentration of NO to be used.
Our Thermo Environmental chemiluminescence analyser (model 42H) including bypass option was purchased for $A23,769 in 1992. A modification was required to comply with Australian medical electrical standards. The cost of the Pulmonox II electrochemical analyser was $A8,750 in 1993. The Bedfont NOxBox is currently listed as $A7,200.
We could not verify the accuracy of two electrochemical monitors. The 95% confidence limits of the differences between the chemiluminescence and electrochemical monitors (Chemiluminescence-Pulmonox electrochemical, +3 to -2; Chemiluminescence-Bedfont electrochemical, -2 to -7 ppm) and their respective limits of agreement (14 to -13 and 2 to -16 ppm) approximate or exceed the probable therapeutic concentration for nitric oxide (0.1 to 3 ppm) 4,5 in some circumstances. Moreover, inspection of Figures 2 and 3 suggests that there is a variable but linear relationship between the chemi-luminescence and both electrochemical measurements. In comparison to the chemiluminescence method, the Pulmonox electrochemical method underreads between approximately 5 and 40 ppm but overreads between approximately 40 and 90 ppm. In contrast, in comparison with the chemiluminescence method, the Bedfont electrochemical method overreads progressively from approximately 5 to 90 ppm. Thus neither electrochemical monitor tested here appears an ideal replacement for the chemiluminescence monitor for NO measurement.
Other investigators have compared electrochemical monitors to chemiluminescence detectors. The Polytron electrochemical monitor (Dräger AG, Lübeck, Germany) in comparison to the Topaze 2020 chemiluminescence monitor (Cosma SA, Igny, France), overestimated NO by a mean of 2.4 ppm with 95% confidence intervals of 3.6 to 1.2 ppm (our calculations) and limits of agreement of the differences of 10 to -5 ppm when tested over a range of 0-100 ppm NO 14 . Fajardo et al demonstrated overreading of nitric oxide in an electrochemical analyser with maximal divergence from initial readings at a mean airway pressure of 15 cm H 2 O and a NO concentration of 40 ppm. Whilst there was a 25.4% over estimation at 40 ppm there was only a 1% overestimation at 10 ppm. The chemiluminescence analyser demonstrated a maximal 4.8% increase in NO reading at 100% humidity and 15 cm H 2 O mean airway pressure 15 . In another comparative study with the Analyser AC2 chemiluminescence monitor (Environment SA, Poissy, France) over a range of 0-30 ppm NO, the Polytron monitor underestimated by a mean of 2.8 ppm with 95% confidence intervals of 3.3 to 2.3 ppm (our calculations) and limits of agreement of the differences of -0.6 and 6.2 ppm 16 . On the basis of these results, the investigators concluded that chemiluminescence monitors can be substituted with the electrochemical monitors during NO therapy. Although this may be reasonable at higher doses of NO, it would not be so at doses less than 5 ppm, which in any case were not studied.
The choice between a chemiluminescence detector and an electrochemical monitor depends to a major extent upon the therapeutic dose of NO and the detection limits of each apparatus. Electrochemical analysers have a detection limit of 1 part per million compared with 1 part per billion for low range chemiluminescence analysers. The therapeutic dose of NO is not yet clearly determined. Some early reports of NO use in spontaneously breathing and ventilated subjects employed concentrations of 40 ppm 17 , and up to 80 ppm 1, 18 . However, improvement in oxygenation in newborn infants with pulmonary hypertension was also observed with 10-20 ppm NO 2 and indeed no difference in responses in similar conditions were noted with doses from 5 to 80 ppm 19 . Moreover, the therapeutic concentration for the treatment of hypoxaemia and pulmonary hypertension in ARDS has been reported to be considerably lower at 0.1-3 ppm (100 -3000 ppb) 4, 5 . Thus accuracy at low concentration (1-5 ppm) appears to be a requirement of any NO monitor as major decisions on prognosis and therapeutic options often depend on clinical improvement as measured by decreasing requirements for NO. A drop in requirement from 3 to 1 ppm may only be significant if the measurement error of the analyser is less than 1 ppm. On these grounds, electrochemical monitors do not appear to be suitable substitutes for chemiluminescence monitors, particularly at low dose. No study has reported adequate comparative measurements of doses less than 5 ppm.
Nitric oxide may be measured by spectroscopic and electrochemical methods 20, 21 . Spectroscopic methods include chemiluminescence detection, ultraviolet visible spectroscopy and electron spin resonance spectroscopy. Mass spectrometry and gas chromatography are much less sensitive and are impractical for routine clinical use. Chemiluminescence detection has been adopted for clinical use.
Although the two electrochemical monitors are smaller than the chemiluminescence monitor, operate silently and are less costly, our results do not suggest that either is an ideal replacement. Although they may be adequate to warn of potential toxic concentrations of NO, the differences between the monitors are too great and variable to permit reliable substitution when monitoring low therapeutic concentrations. Comparative studies at less than 5 ppm are needed.
